Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Physical limitations take a significant toll in breast cancer survivors

27.09.2010
Basic physical limitations following breast cancer treatment can have far-reaching consequences that substantially affect how long a patient lives.

According to a new study published online in “The Journal of the National Cancer Institute,” breast cancer survivors with functional limitations – an inability to perform normal daily activities – caused by the disease or its treatment are more likely to die because of overall poorer health.

The scientists found that survivors who reported physical limitations after breast cancer treatment have the same risk of dying from breast cancer as those without limitations but are more likely to die from other diseases. In particular, investigators found that older women, as well as overweight breast cancer patients, were more likely to experience functional impairments for at least 18 months after treatment.

The research, the first of its kind, points to risk factors where, with simple modifications in habits that allow more physical activity, health might be greatly improved.

The impairments, affecting motion, strength and dexterity, include an inability to kneel, to lift items heavier than 10 pounds or to handle small objects, to stand in place, to sit for long periods, to walk up and down a flight a stairs, to walk two or three city blocks.

“Our study provides evidence of why it is important to develop interventions that improve physical function, to mitigate the adverse effects of physical limitations,’’ said Dejana Braithwaite, PhD, first author of the study and assistant professor of Cancer Epidemiology at UCSF’s Helen Diller Family Comprehensive Cancer Center. “Intervention strategies – on the part of the individual, the community and the health provider – should emphasize physically active lifestyles.’’

Braithwaite collaborated with researchers at the Kaiser Permanente Northern California, the University of Utah, the University of California and Brock University in Canada.

“When we talk about improving physical function, we are talking about improving a woman’s ability to perform normal functions of everyday life, like walking around the block, getting up easily from a chair or carrying a heavy bag of groceries,’’ said Bette Caan, DRPH, senior author and principal investigator of the Life After Cancer Epidemiology Study and Senior Research Scientist at Kaiser Permanente Division of Research. “These activities appear to make a difference in a woman’s chance of survival after a breast cancer diagnosis.’’

With better detection and treatment, more breast cancer patients are surviving longer.

According to the National Cancer Institute, an estimated 2.5 million women with a history of breast cancer were alive in 2006 – most of them cancer-free. The overall five-year survival rate for localized breast cancer is 98 percent, reports the American Cancer Society, while the survival rate for breast cancer that has spread to the chest wall or lymph nodes is in the 80 percent range; at least 25 percent of breast cancer patients whose disease has metastasized survive five or more years.

Despite improved survival rates, many patients struggle with physical limitations after treatment – as many as 39 percent, according to the new findings – yet little attention has been paid to those limitations and related problems, particularly among older women.

To determine how physical limitations following initial breast cancer treatment affect mortality, the scientists studied 2,202 women in California and Utah with breast cancer, questioning them about endurance, strength, muscular range of motion, and small muscle dexterity following initial treatment such as chemotherapy, radiation therapy or hormone therapy. The women were part of the Life After Cancer Epidemiology cohort, and were followed for up to 11 years after diagnosis.

Outcomes differed according to disease stage. Women with localized cancer had higher rates of non-breast cancer death due to functional limitations than those with more advanced disease. In addition, women with functional limitations may have poorer treatment tolerance because they are more likely to be older, less physically active, and overweight or obese. As a result, the authors speculate that women with good physical function who tolerated therapy well might be over-represented in the group with more advanced disease.

“There is increasing evidence that regular physical activity, as little as 30 minutes of moderate intensity walking each day, can reduce the risk of breast cancer recurrence,’’ said study co-author Patricia Ganz, MD, a medical oncologist and director of cancer prevention and control at UCLA’s Jonsson Comprehensive Cancer Center. “Women with functional limitations are less likely to be able to maintain regular physical activity and would likely benefit from intervention to reduce their limitations and increase physical activity.’’

Though the researchers did not specifically study the mechanism, they suggest that functional limitations may be associated with chronic inflammation, a key aspect of the immune system’s defenses, which can lead to diminished function of organs or systems.

In an accompanying editorial, Harvey Jay Cohen, MD, director of the Center for the Study of Aging and Human Development at Duke University Medical Center said the research “enhances our broader understanding of the issues surrounding functional status assessment and cancer outcomes.’’ http://jnci.oxfordjournals.org/content/early/2010/09/22/jnci.djq365.full.pdf+html.

The research was supported by grants from the National Institutes of Health, National Cancer Institute, Bay Area Breast Cancer SPORE (Specialized Program of Research Excellence), the Hellman Family Foundation, and the Robert Wood Johnson Foundation Health & Society Scholars Program at the University of California, San Francisco and Berkeley. Data were derived from the LACE study, which was supported by funds from the National Cancer Institute and by the Utah Cancer Registry with additional support from the Utah Department of Health.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.

The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and the society at large. It seeks to understand the determinants of illness and well-being and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 500-plus staff is working on more than 250 epidemiological and health services research projects. For more information, visit http://www.dor.kaiser.org.

Additional contact: Maureen McInaney-Jones, Communications Manager, Kaiser Permanente Division of Research, Northern California, 510-891-3173; Maureen.McInaney@kp.org

Elizabeth Fernandez | EurekAlert!
Further information:
http://www.ucsf.edu

More articles from Health and Medicine:

nachricht Penn studies find promise for innovations in liquid biopsies
30.03.2017 | University of Pennsylvania School of Medicine

nachricht 'On-off switch' brings researchers a step closer to potential HIV vaccine
30.03.2017 | University of Nebraska-Lincoln

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

'On-off switch' brings researchers a step closer to potential HIV vaccine

30.03.2017 | Health and Medicine

Penn studies find promise for innovations in liquid biopsies

30.03.2017 | Health and Medicine

An LED-based device for imaging radiation induced skin damage

30.03.2017 | Medical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>